2021
DOI: 10.3390/pharmaceutics13111893
|View full text |Cite
|
Sign up to set email alerts
|

Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation

Abstract: Hydroxamic acids are one of the most promising and actively studied classes of chemical compounds in medicinal chemistry. In this study, we describe the directed synthesis and effects of HDAC6 inhibitors. Fragments of adamantane and natural terpenes camphane and fenchane, combined with linkers of various nature with an amide group, were used as the CAP groups. Accordingly, 11 original target compounds were developed, synthesized, and exposed to in vitro and in vivo biological evaluations, including in silico m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 78 publications
2
10
0
Order By: Relevance
“…One of the most important properties of the adamantane-derived compounds is their ability to penetrate through the blood–brain barrier (BBB), which is a key property of a potential neuroprotective drug. Hydroxamic acids with adamantane scaffolds restored normal memory functions in 5xFAD mice that simulated AD to the level observed in control wild-type animals [ 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…One of the most important properties of the adamantane-derived compounds is their ability to penetrate through the blood–brain barrier (BBB), which is a key property of a potential neuroprotective drug. Hydroxamic acids with adamantane scaffolds restored normal memory functions in 5xFAD mice that simulated AD to the level observed in control wild-type animals [ 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, we evaluated the hemolytic activity (i.e., the ability to destroy human erythrocytes) [41][42][43]and biostability in whole mice blood for the leader compounds [44]. The tested compounds do not show hemolytic activity (HC 50 >100 µM) and are metabolized relatively slowly (data are presented in supporting information, Figure S46).…”
Section: Anticancer Activitymentioning
confidence: 99%
“…According to convention, all of the histone deacetylase inhibitors that currently exist can be divided into four large groups: (1) hydroxamic acids, (2) benzamides, (3) cyclic peptides, and (4) aliphatic fatty acids. Meanwhile, of all the HDAC inhibitors, it is hydroxamic acid-based compounds that represent the largest and most clinically successful class due to the fact that they exhibit the most promising profile of pharmacological activity [404][405][406].…”
Section: Advances In the Development Of Histone Deacetylase Inhibitor...mentioning
confidence: 99%